Psychiatric drugs: The role of non-medical mental health professionals (23 June 2022)
Many/most mental health clients take psychiatric drugs.
These drugs, besides short term benefits for some, have a range of adverse effects, including hitherto un-recognised withdrawal effects.
Non-medical professionals are often reluctant to engage with clients on issues relating to their drugs.
The guidance was developed by the BPS and several other professional groups to encourage and facilitate informed, appropriate engagement with clients on these issues: Guidance for Psychological Therapists: Enabling conversation with clients taking or withdrawing from prescribed psychiatric drugs.
There will be
time to ask questions and discuss the ethical/professional issues involved in the
All mental health professionals at all career levels.
This webinar will have an interactive Q&A session.
Please note: This webinar will be available as a recording afterwards for participants with access for 30 days.
- To inform participants about the research on the efficacy and risks of psychiatric drugs, and about the new Guidance
- In particular to learn about recent research documenting the incidence and severity of withdrawal symptoms, especially regarding antidepressants
- To be more confident about meeting their obligation to engage with clients in an informed and therapeutic manner on these issues when appropriate.
- To know where to access more information as needed.
Participants are asked to become familiar with the guidance in preparation for this webinar if they are not familiar with it already.
Post webinar materials
Participants will be provided with the following resources:
- A copy of the Guidance for Psychological Therapists: Enabling conversation with clients taking or withdrawing from prescribed psychiatric drugs.
- Webinar slides
- A copy of the webinar recording.
Dr John Read is Professor of Clinical Psychology at the University of East London.
He is a co-author of 'Guidance for Psychological Therapists: Enabling conversation with clients taking or withdrawing from prescribed psychiatric drugs'
John is Chair of the International Institute for Psychiatric Drug Withdrawal
He has published over 180 research papers, primarily on the relationship between adverse life events and psychosis. He also researches the negative effects of bio-genetic causal explanations on prejudice, the experiences of recipients of anti-psychotic and anti-depressant medication, electroconvulsive therapy, and the role of the pharmaceutical industry in mental health research and practice.
Price: £14.40 (£12.00 + £2.40 VAT)
The price is for everyone who wishes to attend. This is in support of the Memorandum Understanding the society has with partner organisations who were involved in producing the Guidance for Psychological Therapists: Enabling conversation with clients taking or withdrawing from prescribed psychiatric drugs.
Please login to book your place.
This live webinar has been organised by the BPS Professional Development Centre email@example.com